|
Volumn 351, Issue 22, 2004, Pages 2344-2345
|
Methylprednisolone, valacyclovir, or both for vestibular neuritis [4] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
METHYLPREDNISOLONE;
VALACICLOVIR;
VIRUS ANTIGEN;
ACICLOVIR;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
VALINE;
VIRUS DNA;
DNA VIRUS;
DRUG EFFICACY;
ELECTRONYSTAGMOGRAPHY;
GANGLION;
HERPES SIMPLEX VIRUS 1;
HOSPITALIZATION;
HUMAN;
IMMUNE RESPONSE;
LENGTH OF STAY;
LETTER;
PARESIS;
PERSISTENT INFECTION;
PRIORITY JOURNAL;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
VESTIBULAR FUNCTION;
VESTIBULAR NEURONITIS;
VIRUS LATENCY;
DRUG ADMINISTRATION;
DRUG COMBINATION;
NOTE;
PATIENT SELECTION;
HERPES SIMPLEX;
ISOLATION AND PURIFICATION;
PHYSIOLOGY;
VIROLOGY;
METHODOLOGY;
OUTCOME ASSESSMENT;
ACYCLOVIR;
ANTIVIRAL AGENTS;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
HUMANS;
METHYLPREDNISOLONE;
PATIENT SELECTION;
VALINE;
VESTIBULAR NEURONITIS;
DNA, VIRAL;
HERPES SIMPLEX;
HERPESVIRUS 1, HUMAN;
VIRUS LATENCY;
ELECTRONYSTAGMOGRAPHY;
HOSPITALIZATION;
LENGTH OF STAY;
OUTCOME ASSESSMENT (HEALTH CARE);
|
EID: 13644258983
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200411253512222 Document Type: Letter |
Times cited : (6)
|
References (0)
|